Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls

Isolated Diffusion Restriction Precedes the Development of Enhancing Tumor in a Subset of Patients with Glioblastoma

(2011) A. Gupta et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab

(2011) Benjamin M. Ellingson et al.   JOURNAL OF NEURO-ONCOLOGY

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab

(2011) B. M. Ellingson et al.   NEURO-ONCOLOGY

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab

(2011) B. M. Ellingson et al.   NEURO-ONCOLOGY

Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab

(2011) W. B. Pope et al.   NEUROLOGY

Recurrent High-Grade Glioma

(2010) Eudocia C. Quant et al.   Current Treatment Options in Neurology

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

(2010) Benjamin M. Ellingson et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis

(2010) L. R. Rogers et al.   JOURNAL OF NEURO-ONCOLOGY

Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons

(2010) Devyani Bedekar et al.   MAGNETIC RESONANCE IN MEDICINE

Distinction between pyogenic brain abscess and necrotic brain tumour using 3-tesla MR spectroscopy, diffusion and perfusion imaging

(2009) I-C CHIANG et al.   BRITISH JOURNAL OF RADIOLOGY

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Diffusion Magnetic Resonance Imaging Detects Pathologically Confirmed, Nonenhancing Tumor Progression in a Patient With Recurrent Glioblastoma Receiving Bevacizumab

(2009) Elizabeth R. Gerstner et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients

(2009) Johannes Rieger et al.   JOURNAL OF NEURO-ONCOLOGY

Antiangiogenic therapies for high-grade glioma

(2009) Andrew D. Norden et al.   Nature Reviews Neurology

18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: Initial experience

(2008) Carlos J. Ledezma et al.   EUROPEAN JOURNAL OF RADIOLOGY